INSUBCONTINENT EXCLUSIVE:
Fleury Group strengthens its market position through a calculated R$130 million ($22.4 million) acquisition of Confiance Medical Diagnostics
healthcare market where 47% of the 3.1 million residents hold private health insurance
company maintains its debt-to-EBITDA ratio at 1.2x, demonstrating sound financial management
The purchased network processes 5.8 million tests annually across seven cities, including Campinas and surrounding
physical locations and home services.Fleury Expands Medical Diagnostics Empire with R$130 million Acquisition
The company allocates 6% of revenue to capital expenditures, primarily targeting technology upgrades and infrastructure maintenance.This
performance remains solid, with R$5.8 billion ($1 billion) revenue and R$532 million ($91.7 million) net profit in the first nine months
competitive position in a region known for its robust healthcare demand and economic vitality
This strategic move aligns with their goal of expanding quality diagnostic services while maintaining operational efficiency.
